Global Parkinson’s Disease Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Parkinson’s Disease Drugs Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2042516
  • Published Date :
    June 1, 2022
  • Number of Pages :
    300.0

Product Description

The Parkinson’s Disease Drugs market revenue was xx Million USD in 2018, grew to xx Million USD in 2021, and will reach xx Million USD in 2030, with a CAGR of xx during 2022-2030.

Considering the influence of COVID-19 on the global Parkinson’s Disease Drugs market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Parkinson’s Disease Drugs Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Parkinson’s Disease Drugs market are:
UCB S.A
Orion Pharma
Teva Pharmaceutical Industries Ltd.
Vertical Pharmaceuticals, LLC
Impax Laboratories, Inc.
Hoffmann-La Roche Ltd
Novartis AG
Merck & Co., Inc.
ACADIA Pharmaceuticals Inc.
Pfizer, Inc.
Lundbeck A/S

Most important types of Parkinson’s Disease Drugs products covered in this report are:
Decarboxylase Inhibitors
Dopamine Agonists
Monoamine Oxidase Type B (MAO-B) Inhibitor
Catechol-O-Methyltransferase (COMT) Inhibitors
Others

Most widely used downstream fields of Parkinson’s Disease Drugs market covered in this report are:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Table of Content 

Table of Content

1 Parkinson’s Disease Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Parkinson’s Disease Drugs
1.3 Parkinson’s Disease Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Parkinson’s Disease Drugs Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Parkinson’s Disease Drugs
1.4.2 Applications of Parkinson’s Disease Drugs
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Parkinson’s Disease Drugs Industry Trends
1.5.2 Parkinson’s Disease Drugs Drivers
1.5.3 Parkinson’s Disease Drugs Market Challenges
1.5.4 Parkinson’s Disease Drugs Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Parkinson’s Disease Drugs Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Parkinson’s Disease Drugs Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Parkinson’s Disease Drugs Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Parkinson’s Disease Drugs
2.2.1 Major Players Manufacturing Base of Parkinson’s Disease Drugs in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Parkinson’s Disease Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Parkinson’s Disease Drugs
2.3.3 Labor Cost of Parkinson’s Disease Drugs
2.4 Market Channel Analysis of Parkinson’s Disease Drugs
2.5 Major Down Stream Customers by Application

3 Global Parkinson’s Disease Drugs Market, by Type
3.1 Global Parkinson’s Disease Drugs Revenue and Market Share by Type (2018-2021)
3.2 Global Parkinson’s Disease Drugs Production and Market Share by Type (2018-2021)
3.3 Global Parkinson’s Disease Drugs Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Parkinson’s Disease Drugs Revenue and Growth Rate of Decarboxylase Inhibitors
3.3.2 Global Parkinson’s Disease Drugs Revenue and Growth Rate of Dopamine Agonists
3.3.3 Global Parkinson’s Disease Drugs Revenue and Growth Rate of Monoamine Oxidase Type B (MAO-B) Inhibitor
3.3.4 Global Parkinson’s Disease Drugs Revenue and Growth Rate of Catechol-O-Methyltransferase (COMT) Inhibitors
3.3.5 Global Parkinson’s Disease Drugs Revenue and Growth Rate of Others
3.4 Global Parkinson’s Disease Drugs Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends

4 Parkinson’s Disease Drugs Market, by Application
4.1 Downstream Market Overview
4.2 Global Parkinson’s Disease Drugs Consumption and Market Share by Application (2018-2021)
4.3 Global Parkinson’s Disease Drugs Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Hospital Pharmacy (2018-2021)
4.3.2 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Retail Pharmacy (2018-2021)
4.3.3 Global Parkinson’s Disease Drugs Consumption and Growth Rate of Online Pharmacy (2018-2021)

5 Global Parkinson’s Disease Drugs Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Parkinson’s Disease Drugs Revenue and Market Share by Region (2018-2021)
5.2 Global Parkinson’s Disease Drugs Consumption and Market Share by Region (2018-2021)
5.3 Global Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Parkinson’s Disease Drugs Market Under COVID-19
5.4.2 North America Parkinson’s Disease Drugs SWOT Analysis
5.5 Europe Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Parkinson’s Disease Drugs Market Under COVID-19
5.5.2 Europe Parkinson’s Disease Drugs SWOT Analysis
5.6 China Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Parkinson’s Disease Drugs Market Under COVID-19
5.6.2 China Parkinson’s Disease Drugs SWOT Analysis
5.7 Japan Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Parkinson’s Disease Drugs Market Under COVID-19
5.7.2 Japan Parkinson’s Disease Drugs SWOT Analysis
5.8 Middle East and Africa Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Parkinson’s Disease Drugs Market Under COVID-19
5.8.2 Middle East and Africa Parkinson’s Disease Drugs SWOT Analysis
5.9 India Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Parkinson’s Disease Drugs Market Under COVID-19
5.9.2 India Parkinson’s Disease Drugs SWOT Analysis
5.10 South America Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Parkinson’s Disease Drugs Market Under COVID-19
5.10.2 South America Parkinson’s Disease Drugs SWOT Analysis
5.11 South Korea Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Parkinson’s Disease Drugs Market Under COVID-19
5.11.2 South Korea Parkinson’s Disease Drugs SWOT Analysis
5.12 Southeast Asia Parkinson’s Disease Drugs Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Parkinson’s Disease Drugs Market Under COVID-19
5.12.2 Southeast Asia Parkinson’s Disease Drugs SWOT Analysis

6 Global Parkinson’s Disease Drugs Production by Top Regions (2018-2021)
6.1 Global Parkinson’s Disease Drugs Production by Top Regions (2018-2021)
6.2 North America Parkinson’s Disease Drugs Production and Growth Rate
6.3 Europe Parkinson’s Disease Drugs Production and Growth Rate
6.4 China Parkinson’s Disease Drugs Production and Growth Rate
6.5 Japan Parkinson’s Disease Drugs Production and Growth Rate
6.6 India Parkinson’s Disease Drugs Production and Growth Rate

7 Global Parkinson’s Disease Drugs Consumption by Regions (2018-2021)
7.1 Global Parkinson’s Disease Drugs Consumption by Regions (2018-2021)
7.2 North America Parkinson’s Disease Drugs Consumption and Growth Rate
7.3 Europe Parkinson’s Disease Drugs Consumption and Growth Rate
7.4 China Parkinson’s Disease Drugs Consumption and Growth Rate
7.5 Japan Parkinson’s Disease Drugs Consumption and Growth Rate
7.6 Middle East & Africa Parkinson’s Disease Drugs Consumption and Growth Rate
7.7 India Parkinson’s Disease Drugs Consumption and Growth Rate
7.8 South America Parkinson’s Disease Drugs Consumption and Growth Rate
7.9 South Korea Parkinson’s Disease Drugs Consumption and Growth Rate
7.10 Southeast Asia Parkinson’s Disease Drugs Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 UCB S.A Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.2.3 UCB S.A Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Orion Pharma Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.3.3 Orion Pharma Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Teva Pharmaceutical Industries Ltd. Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.4.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Vertical Pharmaceuticals, LLC Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.5.3 Vertical Pharmaceuticals, LLC Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Impax Laboratories, Inc. Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.6.3 Impax Laboratories, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Hoffmann-La Roche Ltd Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.7.3 Hoffmann-La Roche Ltd Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Novartis AG Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.8.3 Novartis AG Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Merck & Co., Inc. Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.9.3 Merck & Co., Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 ACADIA Pharmaceuticals Inc. Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.10.3 ACADIA Pharmaceuticals Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Pfizer, Inc. Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.11.3 Pfizer, Inc. Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Lundbeck A/S Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Parkinson’s Disease Drugs Product Profiles, Application and Specification
8.12.3 Lundbeck A/S Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Parkinson’s Disease Drugs Market Analysis and Forecast by Type and Application
9.1 Global Parkinson’s Disease Drugs Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Decarboxylase Inhibitors Market Revenue and Volume Forecast (2021-2026)
9.1.2 Dopamine Agonists Market Revenue and Volume Forecast (2021-2026)
9.1.3 Monoamine Oxidase Type B (MAO-B) Inhibitor Market Revenue and Volume Forecast (2021-2026)
9.1.4 Catechol-O-Methyltransferase (COMT) Inhibitors Market Revenue and Volume Forecast (2021-2026)
9.1.5 Others Market Revenue and Volume Forecast (2021-2026)
9.2 Global Parkinson’s Disease Drugs Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital Pharmacy Market Revenue and Volume Forecast (2021-2026)
9.2.2 Retail Pharmacy Market Revenue and Volume Forecast (2021-2026)
9.2.3 Online Pharmacy Market Revenue and Volume Forecast (2021-2026)

10 Parkinson’s Disease Drugs Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Parkinson’s Disease Drugs Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?

Search results for Biotechnology Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Agriculture

Biotechnology

Consumer Goods

Top Rated Products